News stories about Unilife Corp (NASDAQ:UNIS) have trended positive this week, according to Accern. The research group ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Unilife Corp earned a media sentiment score of 0.26 on Accern’s scale. Accern also assigned news coverage about the medical instruments supplier an impact score of 45.189228362073 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Shares of Unilife Corp (UNIS) opened at 0.1591 on Wednesday. The stock’s 50 day moving average price is $1.28 and its 200-day moving average price is $2.05. Unilife Corp has a 52-week low of $0.09 and a 52-week high of $6.20.
TRADEMARK VIOLATION NOTICE: This piece was first posted by BBNS and is owned by of BBNS. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/unilife-corp-unis-earns-media-sentiment-score-of-0-26-updated-updated-updated/1249837.html.
About Unilife Corp
Unilife Corp is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies.
Receive News & Ratings for Unilife Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unilife Corp and related companies with our FREE daily email newsletter.